ARTICLE | Distillery Therapeutics
Musculoskeletal
September 20, 2017 6:57 PM UTC
Cell culture studies suggest an RNA-targeting CRISPR-Cas9 construct could help treat DM1 and other diseases caused by microsatellite repeat expansions. The construct consisted of a nuclease-dead Cas9,...
BCIQ Target Profiles